Page 37 - AN-4-2

Advanced Neurology SARS-CoV-2 mechanisms of neurological impact

49. Nordvig AS, Fong KT, Willey JZ, et al. Potential neurologic 60. Beghi E, Helbok R, Ozturk S, et al. Short- and long-term
manifestations of COVID-19. Neurol Clin Pract. outcome and predictors in an international cohort of patients
2021;11(2):e135‑e146. with neuro-COVID-19. Eur J Neurol. 2022;29(6):1663‑1684.
doi: 10.1212/CPJ.0000000000000897 doi: 10.1111/ene.15293
50. Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. 61. Cho SM, White N, Premraj L, et al. Neurological
Immediate and long-term consequences of COVID-19 manifestations of COVID-19 in adults and children. Brain.
infections for the development of neurological disease. 2023;146(4):1648‑1661.
Alzheimers Res Ther. 2020;12(1):69.
doi: 10.1093/brain/awac332
doi: 10.1186/s13195-020-00640-3
62. Beghi E, Moro E, Davidescu EI, et al. Comparative features
51. Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional and outcomes of major neurological complications of
associations between COVID-19 and psychiatric disorder: COVID-19. Eur J Neurol. 2023;30(2):413‑433.
Retrospective cohort studies of 62 354 COVID-19 cases in
the USA. Lancet Psychiatry. 2021;8(2):130‑140. doi: 10.1111/ene.15617
doi: 10.1016/S2215-0366(20)30462-4 63. Chou SH, Beghi E, Helbok R, et al. Global incidence of
neurological manifestations among patients hospitalized
52. Dani M, Dirksen A, Taraborrelli P, et al. Autonomic with COVID-19-a report for the GCS-NeuroCOVID
dysfunction in “long COVID”: Rationale, physiology and consortium and the ENERGY consortium. JAMA Netw
management strategies. Clin Med (Lond). 2021;21(1):e63‑e67. Open. 2021;4(5):e2112131.
doi: 10.7861/clinmed.2020-0896 doi: 10.1001/jamanetworkopen.2021.12131
53. Novak P, Mukerji SS, Alabsi HS, et al. Multisystem 64. Rass V, Beer R, Schiefecker AJ, et al. Neurological outcomes
involvement in post-acute sequelae of coronavirus disease 1 year after COVID-19 diagnosis: A prospective longitudinal
19. Ann Neurol. 2022;91(3):367‑379. cohort study. Eur J Neurol. 2022;29(6):1685‑1696.
doi: 10.1002/ana.26286 doi: 10.1111/ene.15307
54. Mantovani A, Morrone MC, Patrono C, et al. Long covid: 65. Jiao T, Huang Y, Sun H, Yang L. Research progress of post-
Where we stand and challenges ahead. Cell Death Differ. acute sequelae after SARS-CoV-2 infection. Cell Death Dis.
2022;29(10):1891‑1900. 2024;15(4):257.
doi: 10.1038/s41418-022-01052-6 doi: 10.1038/s41419-024-06642-5
55. Griffin DO. Postacute sequelae of COVID (PASC or long 66. Zhang H, Zang C, Xu Z, et al. Data-driven identification of
COVID): An evidenced-based approach. Open Forum Infect post-acute SARS-CoV-2 infection subphenotypes. Nat Med.
Dis. 2024;11(9):ofae462. 2023;29(1):226‑235.
doi: 10.1093/ofid/ofae462 doi: 10.1038/s41591-022-02116-3
56. Balcom EF, Nath A, Power C. Acute and chronic neurological 67. Spudich S, Nath A. Nervous system consequences of
disorders in COVID-19: Potential mechanisms of disease. COVID-19. Science. 2022;375(6578):267‑269.
Brain. 2021;144(12):3576‑3588.
doi: 10.1126/science.abm2052
doi: 10.1093/brain/awab302
68. Sarubbo F, El Haji K, Vidal‑Balle A, Bargay Lleonart J.
57. Fedeli U, Casotto V, Barbiellini Amidei C, et al. Parkinson’s Neurological consequences of COVID-19 and brain related
disease related mortality: Long-term trends and impact of pathogenic mechanisms: A new challenge for neuroscience.
COVID-19 pandemic waves. Parkinsonism Relat Disord. Brain Behav Immun Health. 2022;19:100399.
2022;98:75‑77.
doi: 10.1016/j.bbih.2021.100399
doi: 10.1016/j.parkreldis.2022.04.011
69. Molaverdi G, Kamal Z, Safavi M, et al. Neurological
58. Bhargava A, Szpunar SM, Sharma M, et al. Clinical features complications after COVID-19: A narrative review.
and risk factors for in-hospital mortality from COVID- eNeurologicalSci. 2023;33:100485.
19 infection at a tertiary care medical center, at the onset
of the US COVID-19 pandemic. J Intensive Care Med. doi: 10.1016/j.ensci.2023.100485
2021;36(6):711‑718. 70. Daugherty SE, Guo Y, Heath K, et al. Risk of clinical
doi: 10.1177/08850666211001799 sequelae after the acute phase of SARS-CoV-2 infection:
Retrospective cohort study. BMJ. 2021;373:n1098.
59. Daniels H, Lacey AS, Mikadze D, et al. Epilepsy mortality in
wales during COVID-19. Seizure. 2022;94:39‑42. doi: 10.1136/bmj.n1098
doi: 10.1016/j.seizure.2021.11.017 71. Lund LC, Hallas J, Nielsen H, et al. Post-acute effects of

Volume 4 Issue 2 (2025) 31 doi: 10.36922/an.4909